Nebulized morphine in the palliation of dyspnoea.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 9373577.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Seventeen terminally ill cancer patients with primary or secondary intrathoracic malignancy complaining of breathlessness were treated with nebulized morphine in doses of 20 mg 4-hourly for 48 h. The effect on dyspnoea was evaluated using the Dyspnoea Assessment Questionnaire. Most patients felt less dyspnoeic after 24 h; the effect was maintained, but not improved upon, after 48 h.
Medical subject headings
- Analgesics, Opioid
- Dyspnea
- Lung Neoplasms
- Morphine
- Palliative Care